MedPath

Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantatio

Not Applicable
Conditions
hematological malignat disease, solid tumor, benign disease
Registration Number
JPRN-UMIN000015166
Lead Sponsor
agoya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1 uncontroled infection 2 uncontroled mental disease 3 pregnantor possible pregnant womanan

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 year survival after transplantation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath